KNAW

Research

New approaches to develop thymic regenerative therapy using embryonic stem cells

Pagina-navigatie:


Update content


Title New approaches to develop thymic regenerative therapy using embryonic stem cells
Period 01 / 2007 - unknown
Status Completed
Research number OND1324879
Data Supplier Website EMC

Abstract

Recent studies in mice have identified common thymic epithelial progenitor cells (TEPC) that were capable to re-establish a thymus in-vivo that fully supported thymopoiesis. These TEPC arise solely from endoderm progenitors during embryogenesis. We hypothesised that common TEPC may be generated in-vitro from embryonic stem (ES) cells that have differentiated towards definitive endoderm. It is our aim to develop methods for a controlled in-vitro differentiation of murine embryonic stem cells towards definitive ES cell-derived endoderm and subsequently towards common TEPC, that may further differentiate into mature, functional thymic tissue in-vivo after transplantation. Delineation of these conditions is aimed for in order to develop thymic regenerative cell therapy, which is considered pivotal in the development of allo-SCT. Recently, effective generation of definitive endoderm using a Sox-17 reporter ES celline was demonstrated. Currently, these endodermal cells are selected and further studied in-vivo upon transplantation in mice and in-vitro using different culture conditions.

Related organisations

Related people

Project leader Prof.dr. J.J. Cornelissen

Classification

C10000 Biotechnology
D21500 Histology, cell biology

Go to page top
Go back to contents
Go back to site navigation